Receive our newsletter – data, insights and analysis delivered to you
  1. News
April 7, 2021updated 16 Apr 2021 3:05pm

Skylight and ClinEdge partner to begin clinical research in US

Skylight Health Group has collaborated with ClinEdge to bring clinical research to primary care practices in Massachusetts, US.

Skylight Health Group has collaborated with ClinEdge to bring clinical research to primary care practices in Massachusetts, US.

ClinEdge provides a full suite of services to support clinical research institutions, contract research organisations (CROs), and sponsors.

It aims to develop and increase service lines which positively affect the cost structure, timeliness as well as the accuracy of administering clinical research.

Skylight Health noted that the partnership with ClinEdge will bring clinical research trials investigating a wide range of indications to its clinics beginning with Massachusetts to accelerate growth in the field of research.

These indications include diabetes, Covid-19, arthritis, post-traumatic stress disorder, hypertension, among others.

Through this, patients in Massachusetts will have the opportunity to participate in these clinical trials that may provide access to new therapies, treatments or vaccines.

Content from our partners
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
Patient-centric pharma logistics: How CRYOPDP delivers hope worldwide
Why Asia-Pacific is the next frontier for decentralized clinical trials

Skylight Health Digital Health and Research senior vice-president Christopher Smith said: “At Skylight Health we focus on continually improving the care of our patients through research, data, and innovation.

“This partnership represents an opportunity for our clinics and patients to make meaningful contributions to the improvement of healthcare through clinical research while providing access to new therapies and the potential for subsidiised care.”

Skylight Health also noted that the participation in these clinical trials will be available for existing patients as well as individuals who may not be the company’s patients but are interested in contributing to research.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy